PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil.

IF 3.1 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING EJNMMI Research Pub Date : 2024-12-02 DOI:10.1186/s13550-024-01176-5
Faïza Maloum-Rami, Pierre Cheung, Gunnar Antoni, Zhe Jin, Olof Eriksson, Daniel Espes
{"title":"PET imaging of GABA<sub>A</sub> receptors in pancreatic islets by [<sup>11</sup>C]flumazenil.","authors":"Faïza Maloum-Rami, Pierre Cheung, Gunnar Antoni, Zhe Jin, Olof Eriksson, Daniel Espes","doi":"10.1186/s13550-024-01176-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressive β-cell destruction. There are no clinically established methods for quantifying endocrine cells of the pancreas and current knowledge is almost exclusively based on autopsy material and functional measurements. Based on the expression of the γ-aminobutyric acid A receptors (GABA<sub>A</sub>Rs) in pancreatic islets and the fact that GABA<sub>A</sub>R agonists are being explored as treatment for T1D, we hypothesized that the positron emission tomography (PET) tracer [<sup>11</sup>C]flumazenil ([<sup>11</sup>C]FMZ) could serve as a marker of the endocrine mass of the pancreas. The in vivo uptake of [<sup>11</sup>C]FMZ in pig pancreas was evaluated by PET/CT, either tracer alone or after blockade of GABA<sub>A</sub>R by unlabeled flumazenil. The pancreatic binding of [<sup>11</sup>C]FMZ was investigated in vitro with frozen sections of pig pancreas as well as human organ donors, in addition to isolated mouse and human islets and exocrine preparations. The expression of GABA<sub>A</sub>R subunits in pig, human and mouse pancreas was explored by immunohistochemistry.</p><p><strong>Results: </strong>Strong specific in vivo uptake of [<sup>11</sup>C]FMZ was observed in the pig brain as expected, but in the pancreas the signal was moderate and only partially reduced by blockade. In vitro experiments revealed a positive but weak and variable binding of [<sup>11</sup>C]FMZ in islets compared to exocrine tissue in the mouse, pig and human pancreas. In pig and mouse pancreatic islets we identified the GABA<sub>A</sub>R subunits β2 and γ2 but not α2. In the human pancreas from non-diabetic donors, we have identified the α2, β2 (although weak) and γ2 subunits, whereas from a T2D donor the α2 subunit was missing.</p><p><strong>Conclusions: </strong>Our findings suggest that [<sup>11</sup>C]FMZ bind to GABA<sub>A</sub>Rs in the islets, but not with a sufficient contrast or magnitude to be implemented as an in vivo PET marker for the endocrine mass of the pancreas. However, GABA<sub>A</sub>Rs with different subunits are widely expressed in the endocrine cells within the pancreas in pig, human and mouse. Hence, the GABA<sub>A</sub>R could still be a potential imaging target for the endocrine cells of the pancreas but would require tracers with higher affinity and selectivity for individual GABA<sub>A</sub>R subunits.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"14 1","pages":"122"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11612099/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-024-01176-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressive β-cell destruction. There are no clinically established methods for quantifying endocrine cells of the pancreas and current knowledge is almost exclusively based on autopsy material and functional measurements. Based on the expression of the γ-aminobutyric acid A receptors (GABAARs) in pancreatic islets and the fact that GABAAR agonists are being explored as treatment for T1D, we hypothesized that the positron emission tomography (PET) tracer [11C]flumazenil ([11C]FMZ) could serve as a marker of the endocrine mass of the pancreas. The in vivo uptake of [11C]FMZ in pig pancreas was evaluated by PET/CT, either tracer alone or after blockade of GABAAR by unlabeled flumazenil. The pancreatic binding of [11C]FMZ was investigated in vitro with frozen sections of pig pancreas as well as human organ donors, in addition to isolated mouse and human islets and exocrine preparations. The expression of GABAAR subunits in pig, human and mouse pancreas was explored by immunohistochemistry.

Results: Strong specific in vivo uptake of [11C]FMZ was observed in the pig brain as expected, but in the pancreas the signal was moderate and only partially reduced by blockade. In vitro experiments revealed a positive but weak and variable binding of [11C]FMZ in islets compared to exocrine tissue in the mouse, pig and human pancreas. In pig and mouse pancreatic islets we identified the GABAAR subunits β2 and γ2 but not α2. In the human pancreas from non-diabetic donors, we have identified the α2, β2 (although weak) and γ2 subunits, whereas from a T2D donor the α2 subunit was missing.

Conclusions: Our findings suggest that [11C]FMZ bind to GABAARs in the islets, but not with a sufficient contrast or magnitude to be implemented as an in vivo PET marker for the endocrine mass of the pancreas. However, GABAARs with different subunits are widely expressed in the endocrine cells within the pancreas in pig, human and mouse. Hence, the GABAAR could still be a potential imaging target for the endocrine cells of the pancreas but would require tracers with higher affinity and selectivity for individual GABAAR subunits.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[11C]氟马西尼对胰岛GABAA受体的PET成像。
背景:1型糖尿病(T1D)是一种以进行性β细胞破坏为特征的自身免疫性疾病。临床上还没有建立定量胰腺内分泌细胞的方法,目前的知识几乎完全基于尸检材料和功能测量。基于胰岛γ-氨基丁酸A受体(γ-氨基丁酸A receptor, GABAARs)的表达,以及GABAAR激动剂正在探索作为T1D治疗的事实,我们假设正电子发射断层扫描(PET)示踪剂[11C]氟马西尼([11C]FMZ)可以作为胰腺内分泌肿块的标志物。通过PET/CT评估猪胰腺对[11C]FMZ的体内摄取,无论是单独示踪剂还是未标记的氟马西尼阻断GABAAR后。体外研究了[11C]FMZ与猪胰腺、人类器官供体、小鼠和人离体胰岛和外分泌制剂的冷冻切片对胰腺的结合。采用免疫组化方法研究GABAAR亚基在猪、人和小鼠胰腺中的表达。结果:与预期一样,在猪脑中观察到强烈的[11C]FMZ的体内特异性摄取,但在胰腺中,信号是中等的,仅部分被阻断。体外实验显示,与小鼠、猪和人胰腺的外分泌组织相比,[11C]FMZ在胰岛中的结合呈阳性,但弱且可变。在猪和小鼠胰岛中,我们发现了GABAAR亚基β2和γ2,但未发现α2。在非糖尿病供者的胰腺中,我们发现了α2、β2(虽然较弱)和γ2亚基,而在T2D供者的胰腺中,α2亚基缺失。结论:我们的研究结果表明[11C]FMZ与胰岛中的GABAARs结合,但没有足够的对比度或强度作为胰腺内分泌肿块的体内PET标记物。然而,不同亚基的GABAARs在猪、人和小鼠胰腺内的内分泌细胞中广泛表达。因此,GABAAR仍可能是胰腺内分泌细胞的潜在成像靶标,但需要对GABAAR亚基具有更高亲和力和选择性的示踪剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
EJNMMI Research
EJNMMI Research RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍: EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies. The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
期刊最新文献
Venous blood sampling for less invasive in vivo quantification of synaptic density with constant infusion of [18F]SynVesT-1 and PET. Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson's disease. 68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study. 68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism. Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1